18704197	Adenosine Triphosphate	Lo Bianco C	Hsp104 antagonizes alpha-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease.	The Journal of clinical investigation	2008	60
12504863	Dopamine	Sherer TB	Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation.	Experimental neurology	2003	108
16227205	Dopamine	Zhou W	DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity.	The Journal of biological chemistry	2005	99
16611810	Dopamine	Tofaris GK	Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders.	The Journal of neuroscience 	2006	69
17965867	Dopamine	Burke WJ	Aggregation of alpha-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine.	Acta neuropathologica	2008	56
21712347	Dopamine	Decressac M	GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease.	Brain 	2011	43
22319455	Dopamine	Butler EK	The mitochondrial chaperone protein TRAP1 mitigates α-Synuclein toxicity.	PLoS genetics	2012	36
23610405	Dopamine	Decressac M	TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity.	Proceedings of the National Academy of Sciences of the United States of America	2013	126
16847061	Bacitracin	Atkin JD	Induction of the unfolded protein response in familial amyotrophic lateral sclerosis and association of protein-disulfide isomerase with superoxide dismutase 1.	The Journal of biological chemistry	2006	89
17360908	beta-amyloid peptide 1-42 (E22delta) click peptide	Shankar GM	Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway.	The Journal of neuroscience 	2007	469
